Decreased expression of galectin-3 is associated with metastatic potential of liver fluke-associated cholangiocarcinoma

European Journal of Cancer

Volumn 44, Issue 4, 2008, Pages 619-626

  Junking, Mutita ^a,b   Wongkham, Chaisiri ^a,b   Sripa, Banchob ^b   Sawanyawisuth, Kanlayanee ^a,b   Araki, Norie ^c   Wongkham, Sopit ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bile duct; Cholangiocarcinoma; Galectin; Galectin 3; LGALS3; Liver fluke; Metastasis; Migration

Indexed keywords

GALECTIN 3; SMALL INTERFERING RNA;

ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FASCIOLA HEPATICA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ADULT; AGED; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CHOLANGIOCARCINOMA; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TRANSFECTION;

EID: 40449105010     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.01.014     Document Type: Article

References (33)

1. Gray C.A., Adelson D.L., Bazer F.W., Burghardt R.C., Meeusen E.N., and Spencer T.E. Discovery and characterization of an epithelial-specific galectin in the endometrium that forms crystals in the trophectoderm. Proc Natl Acad Sci USA 101 21 (2004) 7982-7987
2. Raz A., Zhu D.G., Hogan V., et al. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer 46 5 (1990) 871-877
3. Castronovo V., Van Den Brule F.A., Jackers P., et al. Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 179 1 (1996) 43-48
4. 2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 59 24 (1999) 6239-6245
5. Ochieng J., Furtak V., and Lukyanov P. Extracellular functions of galectin-3. Glycoconj J 19 7-9 (2004) 527-535
6. Yu F., Finley Jr. R.L., Raz A., and Kim H.R. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J Biol Chem 277 18 (2002) 15819-15827
7. Takenaka Y., Fukumori T., Yoshii T., et al. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol Cell Biol 24 10 (2004) 4395-4406
8. Patterson R.J., Wang W., and Wang J.L. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj J 19 7-9 (2004) 499-506
9. Shimura T., Takenaka Y., Tsutsumi S., Hogan V., Kikuchi A., and Raz A. Galectin-3, a novel binding partner of beta-catenin. Cancer Res 64 18 (2004) 6363-6367
10. Sripa B., Kaewkes S., Sithithaworn P., et al. Liver fluke induces cholangiocarcinoma. PLoS Med 4 7 (2007) e201
11. Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., and Thomas H.C. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37 6 (2002) 806-813
12. Thamavit W., Bhamarapravati N., Sahaphong S., Vajrasthira S., and Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 38 12 (1978) 4634-4639
13. Vatanasapt V., Tangvoraphonkchai V., Titapant V., Pipitgool V., Viriyapap D., and Sriamporn S. A high incidence of liver cancer in Khon Kaen Province, Thailand. Southeast Asian J Trop Med Public Health 21 3 (1990) 489-494
14. Vatanasapt V., Uttaravichien T., Mairiang E.O., Pairojkul C., Chartbanchachai W., and Haswell-Elkins M. Cholangiocarcinoma in north-east Thailand. Lancet 335 8681 (1990) 116-117
15. Sithithaworn P., Haswell-Elkins M.R., Mairiang P., et al. Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand. Int J Parasitol 24 6 (1994) 833-843
16. Brustmann H. Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions. Int J Gynecol Pathol 25 1 (2006) 30-37
17. Song Y.K., Billiar T.R., and Lee Y.J. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 160 3 (2002) 1069-1075
18. Greene F.L., Page D.L., Fleming I.D., et al. AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
19. Sripa B., Leungwattanawanit S., Nitta T., et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 11 22 (2005) 3392-3397
20. Elbashir S.M., Harborth J., Weber K., and Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26 2 (2002) 199-213
21. Sawanyawisuth K., Wongkham C., Pairojkul C., et al. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Acta Oncol 46 3 (2007) 378-385
22. van den Brule F., Califice S., and Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J 19 7-9 (2004) 537-542
23. Shimonishi T., Miyazaki K., Kono N., et al. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol 32 3 (2001) 302-310
24. Su C.H., Tsay S.H., Wu C.C., et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 223 4 (1996) 384-394
25. Kawarada Y., Yamagiwa K., and Das B.C. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 183 6 (2002) 679-685
26. Lotz M.M., Andrews Jr. C.W., Korzelius C.A., et al. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 90 8 (1993) 3466-3470
27. van den Brule F.A., Berchuck A., Bast R.C., et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 30A 8 (1994) 1096-1099
28. Takano T., Miyauchi A., Yoshida H., Kuma K., and Amino N. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 219 1 (2005) 91-96
29. Matarrese P., Tinari N., Semeraro M.L., Natoli C., Iacobelli S., and Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 473 3 (2000) 311-315
30. Califice S., Castronovo V., Bracke M., and van den Brule F. Dual activities of galectin-3 in human prostate cancer: tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene 23 45 (2004) 7527-7536
31. Honjo Y., Inohara H., Akahani S., et al. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6 12 (2000) 4635-4640
32. Goletz S., Hanisch F.G., and Karsten U. Novel alpha-GalNAc containing glycans on cytokeratins are recognized invitro by galectins with type II carbohydrate recognition domains. J Cell Sci 110 Pt 14 (1997) 1585-1596
33. Dumic J., Dabelic S., and Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 1760 4 (2006) 616-635